Subjects | Non-diabetic controls | All type 2 diabetics | Euthyroid diabetics | Hyperthyroid diabetics | Hypothyroid diabetics | ||||||
NO | 105 | 162 | 87 | 43 | 32 | ||||||
Analysis | r | p | r | p | r | p | r | p | r | p | |
BMI vs. TC | 0.265 | 0.006** | 0.247 | 0.0168* | 0.274 | 0.017* | 0.295 | 0.008** | 0.169 | 0.278 | |
BMI vs. HDL-C | 0.034 | 0.734 | -0.188 | 0.018* | −0.273 | 0.017* | 0.065 | 0.652 | 0.O34 | 0.780 | |
BMI vs. LDL-C | 0.249 | 0.010* | 0.291 | 0.002** | 0.252 | 0.0228* | 0.346 | 0.002** | 0.002 | 0.992 | |
BMI vs. VLDL-C | 0.023 | 0.686 | 0.025 | 0.790 | 0.173 | 0.095 | 0.032 | 0.686 | 0.025 | 0.792 | |
BMI vs. HDL-L/LDL-L | −0.510 | <−0.0001** | −0.475 | <0.001** | −0.304 | 0.006** | −0.304 | 0.006** | −0.238 | 0.013* | |
BMI vs. TG | 0.072 | 0.812 | 0.034 | 0.720 | 0.068 | 0.501 | 0.069 | 0.384 | 0.005 | 0.960 | |
Cut off point | FT4 = 0.78 - 2.20 ng/dl | - | FT4 = 0.78 - 2.20 ng/dl | FT4 < 0.78 ng/dl | FT4 > 2.20 ng/dl | ||||||